In a proof of principle, a novel approach using the CRISPR methodology to immunotherapy has been developed and proved efficient in pre-clinical trials. It has the advantage that is applicable to a wide range of blood cancer types. If confirmed in clinical experiments, the approach could be a new therapy again leukaemia.
related: #leukaemia #CRISPR
Contact: info(@)neat-news(dot)com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
Note that photos are usually stock photos, mostly taken from
Wikipedia, which we can use royalty-free either since they are in
the public domain or available under an open licence such as
a share alike licence.
The page is maintained in Germany and for any legal matters the
laws of Germany apply.
Any warranty or liability is excluded in the widest legally
possible sense.
© neat-news.com 2016-2025.
